These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19516200)

  • 1. Cardiac markers.
    O Collinson P
    Br J Hosp Med (Lond); 2009 Jun; 70(6):M84-7. PubMed ID: 19516200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical biomarkers of cardiac injury: cardiac troponins and natriuretic peptides.
    Apple FS
    Toxicol Pathol; 2006; 34(1):91-3. PubMed ID: 16507549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in the emergency workup of chest pain: uses, limitations, and future.
    Mosleh W; Abdel-Qadir H; Farkouh M
    Cleve Clin J Med; 2013 Sep; 80(9):589-98. PubMed ID: 24001967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac biomarkers in chronic renal disease.
    Collinson PO; Gaze DC
    Scand J Clin Lab Invest Suppl; 2008; 241():104-8. PubMed ID: 18569976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whose heart will get broken? Troponin testing and future heart failure.
    van Kimmenade RR; Januzzi JL
    Eur Heart J; 2009 Apr; 30(7):755-6. PubMed ID: 19264751
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac troponins in renal failure - time for an optimistic consensus?
    Buhaescu I; Izzedine H; Covic A
    Int J Clin Pract; 2005 Nov; 59(11):1317-25. PubMed ID: 16236087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac markers (BNP, NT-pro-BNP, Troponin I, Troponin T, in female amateur runners before and up until three days after a marathon.
    Frassl W; Kowoll R; Katz N; Speth M; Stangl A; Brechtel L; Joscht B; Boldt LH; Meier-Buttermilch R; Schlemmer M; Roecker L; Gunga HC
    Clin Lab; 2008; 54(3-4):81-7. PubMed ID: 18630737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-associated increases in cardiac biomarkers.
    Scharhag J; George K; Shave R; Urhausen A; Kindermann W
    Med Sci Sports Exerc; 2008 Aug; 40(8):1408-15. PubMed ID: 18614952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac biomarkers in neonatal hypoxic ischaemia.
    Sweetman D; Armstrong K; Murphy JF; Molloy EJ
    Acta Paediatr; 2012 Apr; 101(4):338-43. PubMed ID: 22118561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of cardiovascular damage.
    Collinson PO; Gaze DC
    Med Princ Pract; 2007; 16(4):247-61. PubMed ID: 17541289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cardiac biomarkers in neonatology.
    Vijlbrief DC; Benders MJ; Kemperman H; van Bel F; de Vries WB
    Pediatr Res; 2012 Oct; 72(4):337-43. PubMed ID: 22797141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troponin T or troponin I or CK-MB (or none?).
    Collinson PO
    Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [B-type natriuretic peptide and high sensitivity troponin T as a marker of cardiac failure in patients after permanent cardiac pacing].
    Sielski J
    Pol Merkur Lekarski; 2014 Mar; 36(213):165-70. PubMed ID: 24779213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and significance of detectable troponins as measured by highly sensitive assays in the general population.
    de Lemos JA; deFilippi CR
    Coron Artery Dis; 2013 Dec; 24(8):705-9. PubMed ID: 24201087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardization of cardiac markers.
    Apple FS
    Scand J Clin Lab Invest Suppl; 2005; 240():107-11. PubMed ID: 16112967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying cardiac hemodynamic stress and cardiomyocyte damage in ischemic and nonischemic acute heart failure.
    Drexler B; Heinisch C; Balmelli C; Lassus J; Siirilä-Waris K; Arenja N; Socrates T; Noveanu M; Potocki M; Meune C; Haaf P; Degen C; Breidthardt T; Reichlin T; Nieminen MS; Veli-Pekka H; Osswald S; Mueller C
    Circ Heart Fail; 2012 Jan; 5(1):17-24. PubMed ID: 21976469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac biomarkers in Takotsubo cardiomyopathy.
    Doyen D; Moceri P; Chiche O; Schouver E; Cerboni P; Chaussade C; Mansencal N; Ferrari E
    Int J Cardiol; 2014 Jul; 174(3):798-801. PubMed ID: 24794960
    [No Abstract]   [Full Text] [Related]  

  • 20. [Troponin elevation--differential diagnostic considerations and prognostic importance].
    Jensen JK; Mickley H
    Ugeskr Laeger; 2003 Apr; 165(15):1541-5. PubMed ID: 12715654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.